---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-297658"
form_type: "8-K"
ticker: "RMD"
cik: "0000943819"
company_name: "RESMED INC"
filed_at: "2026-07-07T21:24:32+00:00"
generated_at: "2026-07-07T21:26:04.267659+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# ResMed sells MatrixCare to Frazier Healthcare for $490M cash; sharpens focus on sleep health

## Summary
- All-cash deal valued at $490M, subject to closing adjustments; expected to close in Q1 FY2027.
- MatrixCare had ~$220M revenue and ~$55M non-GAAP operating profit in FY2026.
- Net proceeds to be used for share repurchases (ASR) and general corporate purposes.
- Noctrix acquisition expected to add ~$30M revenue but reduce non-GAAP diluted EPS by ~$0.20 in FY2027.
- ResMed reiterates FY2026 non-GAAP margin, SG&A, R&D, and tax rate outlook; full FY2027 guidance on Aug 6 call.

## SEC filing metadata
- accession: 0001193125-26-297658
- form_type: 8-K
- ticker: RMD
- cik: 0000943819
- company_name: RESMED INC
- filed_at: 2026-07-07T21:24:32+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/943819/000119312526297658/0001193125-26-297658-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/943819/000119312526297658/d88958d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-297658
- JSON: https://secwatch.observer/filing/0001193125-26-297658.json
- Plain text: https://secwatch.observer/filing/0001193125-26-297658.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.